Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy

The presented work is based on the quantification of LN-5, FN, and COL IV in blood plasma as potential biomarkers in patients diagnosed with glioma in grades G1 to G4. The obtained concentration results were compared with the protein content in the control group, which consisted of smokers of differ...

Full description

Bibliographic Details
Main Authors: Lukasz Oldak, Sylwia Chludzinska-Kasperuk, Patrycja Milewska, Kamil Grubczak, Joanna Reszec, Ewa Gorodkiewicz
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/9/2290
_version_ 1827663174712688640
author Lukasz Oldak
Sylwia Chludzinska-Kasperuk
Patrycja Milewska
Kamil Grubczak
Joanna Reszec
Ewa Gorodkiewicz
author_facet Lukasz Oldak
Sylwia Chludzinska-Kasperuk
Patrycja Milewska
Kamil Grubczak
Joanna Reszec
Ewa Gorodkiewicz
author_sort Lukasz Oldak
collection DOAJ
description The presented work is based on the quantification of LN-5, FN, and COL IV in blood plasma as potential biomarkers in patients diagnosed with glioma in grades G1 to G4. The obtained concentration results were compared with the protein content in the control group, which consisted of smokers of different ages. The obtained results were statistically analysed and interpreted based on the available clinical description. Quantitative determinations of LN-5, FN, and COL IV were performed with the use of SPRi biosensors specific to the tested proteins. Comparing groups K and G4, as well as G2 and G4, statistically significant relationships between changes in the concentration of individual proteins, were observed. The analysis showed significant correlations between FN and LN-5, between FN and COL IV, and between LN-5 and COL IV. There was a moderate positive correlation between individual proteins and the age of the patient. The ROC analysis distinguished patients with advanced disease from the control group. The results of the research show that LN-5, FN, and COL IV are effective biomarkers of brain glioma that may be helpful in non-invasive diagnosis and determining the grade of the disease.
first_indexed 2024-03-10T00:38:13Z
format Article
id doaj.art-41de85385d06401284052899be6a95e0
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T00:38:13Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-41de85385d06401284052899be6a95e02023-11-23T15:12:19ZengMDPI AGBiomedicines2227-90592022-09-01109229010.3390/biomedicines10092290Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma MalignancyLukasz Oldak0Sylwia Chludzinska-Kasperuk1Patrycja Milewska2Kamil Grubczak3Joanna Reszec4Ewa Gorodkiewicz5Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, PolandBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandBioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, PolandThe presented work is based on the quantification of LN-5, FN, and COL IV in blood plasma as potential biomarkers in patients diagnosed with glioma in grades G1 to G4. The obtained concentration results were compared with the protein content in the control group, which consisted of smokers of different ages. The obtained results were statistically analysed and interpreted based on the available clinical description. Quantitative determinations of LN-5, FN, and COL IV were performed with the use of SPRi biosensors specific to the tested proteins. Comparing groups K and G4, as well as G2 and G4, statistically significant relationships between changes in the concentration of individual proteins, were observed. The analysis showed significant correlations between FN and LN-5, between FN and COL IV, and between LN-5 and COL IV. There was a moderate positive correlation between individual proteins and the age of the patient. The ROC analysis distinguished patients with advanced disease from the control group. The results of the research show that LN-5, FN, and COL IV are effective biomarkers of brain glioma that may be helpful in non-invasive diagnosis and determining the grade of the disease.https://www.mdpi.com/2227-9059/10/9/2290gliomalaminin-5fibronectintype IV collagenSPRi biosensorsbasement membrane in carcinoma
spellingShingle Lukasz Oldak
Sylwia Chludzinska-Kasperuk
Patrycja Milewska
Kamil Grubczak
Joanna Reszec
Ewa Gorodkiewicz
Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
Biomedicines
glioma
laminin-5
fibronectin
type IV collagen
SPRi biosensors
basement membrane in carcinoma
title Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
title_full Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
title_fullStr Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
title_full_unstemmed Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
title_short Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
title_sort laminin 5 fibronectin and type iv collagen as potential biomarkers of brain glioma malignancy
topic glioma
laminin-5
fibronectin
type IV collagen
SPRi biosensors
basement membrane in carcinoma
url https://www.mdpi.com/2227-9059/10/9/2290
work_keys_str_mv AT lukaszoldak laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy
AT sylwiachludzinskakasperuk laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy
AT patrycjamilewska laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy
AT kamilgrubczak laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy
AT joannareszec laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy
AT ewagorodkiewicz laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy